Merck & Co Inc (MRK)
131.12
-0.61
(-0.46%)
USD |
NYSE |
May 16, 12:23
Merck Cash from Financing (Quarterly): -2.814B for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.814B |
| December 31, 2023 | -2.245B |
| September 30, 2023 | -4.269B |
| June 30, 2023 | 3.758B |
| March 31, 2023 | -2.054B |
| December 31, 2022 | -1.554B |
| September 30, 2022 | -2.702B |
| June 30, 2022 | -1.777B |
| March 31, 2022 | -3.086B |
| December 31, 2021 | 5.207B |
| September 30, 2021 | -2.274B |
| June 30, 2021 | 1.758B |
| March 31, 2021 | -2.098B |
| December 31, 2020 | 1.372B |
| September 30, 2020 | -3.851B |
| June 30, 2020 | 1.137B |
| March 31, 2020 | -1.49B |
| December 31, 2019 | -2.011B |
| September 30, 2019 | -3.152B |
| June 30, 2019 | -2.084B |
| March 31, 2019 | -1.614B |
| December 31, 2018 | -5.566B |
| September 30, 2018 | -1.905B |
| June 30, 2018 | -2.967B |
| March 31, 2018 | -2.722B |
| Date | Value |
|---|---|
| December 31, 2017 | -5.785B |
| September 30, 2017 | 536.00M |
| June 30, 2017 | -6.218B |
| March 31, 2017 | 1.461B |
| December 31, 2016 | -1.977B |
| September 30, 2016 | -835.00M |
| June 30, 2016 | -3.366B |
| March 31, 2016 | -2.866B |
| December 31, 2015 | -2.406B |
| September 30, 2015 | -2.539B |
| June 30, 2015 | -5.597B |
| March 31, 2015 | 5.155B |
| December 31, 2014 | -9.772B |
| September 30, 2014 | 1.279B |
| June 30, 2014 | -8.369B |
| March 31, 2014 | 1.62B |
| December 31, 2013 | -2.624B |
| September 30, 2013 | -2.915B |
| June 30, 2013 | 970.00M |
| March 31, 2013 | -1.421B |
| December 31, 2012 | -1.218B |
| September 30, 2012 | -738.00M |
| June 30, 2012 | -586.00M |
| March 31, 2012 | -725.00M |
| December 31, 2011 | -2.231B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.269B
Minimum
Sep 2023
5.207B
Maximum
Dec 2021
-1.211B
Average
-2.069B
Median
Cash from Financing (Quarterly) Benchmarks
| Amgen Inc | -1.708B |
| Johnson & Johnson | 546.00M |
| Eli Lilly and Co | -311.30M |
| Pfizer Inc | -4.931B |
| Moderna Inc | 14.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.09B |
| Cash from Investing (Quarterly) | -1.376B |
| Free Cash Flow | 11.04B |
| Free Cash Flow Per Share (Quarterly) | 0.8762 |
| Free Cash Flow to Equity (Quarterly) | 3.065B |
| Free Cash Flow to Firm (Quarterly) | 2.422B |
| Free Cash Flow Yield | 3.31% |